Dr Kathleen Holloway was WHO Regional Advisor on Medicines for South East Asia until 2016. She is a UK doctor specialised in the public health of pharmaceuticals in low/middle-income countries, with an interest in promoting the appropriate use of medicines, including antibiotics.
After qualifying she worked in both hospital medicine and general practice in the UK NHS for 11 years and gained membership of both the Royal College of Physicians and General Practitioners. After that she went to work for various NGOs in Asia, including Nepal, India and Myanmar for 10 years. During this time, she worked on TB, leprosy and malaria control, as well as an essential drug program in Nepal. She also gained her Masters of Public Health and a PhD on the Impact of User Fees on Prescribing Quality in Nepal.
From 1999 – 2010, she worked for the WHO in Geneva, where she led a programme on promoting rational use of medicines. Whilst there, she also led the programme on containing antimicrobial resistance for 3 years. During this time, she organised many international training and research programmes, developed a global database on medicines use in primary care in low/middle-income countries, and was the technical officer responsible for WHO resolutions on antimicrobial resistance in 2005 and rational use of medicines in 2007.
From 2010 until her retirement in 2016, in her role as WHO Regional Advisor in Medicines in South-East Asia, she was responsible for providing advice to the governments of the region on all aspects of medicines management. During this time, she developed a method for government officials to undertake a rapid appraisal of medicines management for use in planning and advocacy. She is now based at the Institute of Development Studies (IDS) on the University of Sussex campus.